查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403381

到 2030 年兒童神經設備市場預測：按產品類型、病理、年齡層、服務/治療、神經亞專門食品、最終用戶和地區進行的全球分析

Pediatric Neurology Devices Market Forecasts to 2030 - Global Analysis By Product Type, Condition, Age Group, Service and Treatment, Neurological Subspecialties, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球兒童神經設備市場規模為 33 億美元，預計在預測期內將以 9.8% 的複合年成長率成長，到 2030 年達到 64 億美元。

專門用於診斷、監測和治療兒童神經系統疾病的醫療設備稱為兒童神經設備。這些設備可治療癲癇、腦性麻痹和發育遲緩等疾病，包括腦電圖 (EEG)、兒童用MRI 和復健 CT 掃描儀等各種設備。

根據偏頭痛研究基金會的報告，一半的偏頭痛患者在 12 歲之前首次發作，偏頭痛可能發生在年僅 18 個月大的兒童身上。

對政府計劃和計劃的需求不斷成長

政府舉措透過提供資金、鼓勵團隊合作和支持先進診斷和治療設備的開發來培養兒童神經病學領域的創造力，最終改善患者的治療結果。此外，此類舉措提高了人們對兒童神經系統疾病和專業治療重要性的認知。因此，只要各國政府繼續高度重視兒童醫療保健和研究，兒童神經設備的開發和創新就會持續下去，從而推動該市場的成長。

高成本

專門的兒童神經設備的研究、開發和製造通常需要廣泛的研究並且成本高。由於高成本，設備價格可能急劇上升，許多患者和醫療保健提供者無法負擔。醫療保健系統的財務負擔可能會限制投資於兒童神經病學治療的最新技術和進步的能力。此外，患者、醫療保健提供者和醫療保健系統的潛在經濟負擔也是兒童神經科設備行業高定價的主要缺點之一。

技術進步

醫療技術的不斷創新正在導致更有效、侵入性更小的設備的開發，用於診斷、監測和治療兒童神經系統疾病。這些進步包括先進的神經影像技術、神經刺激設備和提高手術精確度和安全性的手術器械。此外，這些創新為醫療保健專業人員提供了日益複雜的工具，以改善患者的治療效果，減少與治療相關的不適，並提高兒童患者的生活品質，有助於擴大該市場。

缺乏意識

由於缺乏了解，兒童神經病學設備的採用和使用有限是一個重大缺陷。患者、醫療保健專業人員和醫療專業人員可能不了解所有可用技術或其潛在好處。此外，這可能會導致忽視或延遲使用兒童神經科設備，最終影響患者護理。缺乏意識會減慢該領域的創新和研究步伐，這可能是縮小市場規模的一個因素。

COVID-19 的影響

COVID-19大流行對兒童神經設備市場產生了負面影響，這主要是由於醫療保健系統的中斷和經濟的不確定性。封鎖和限制減少了選擇性手術和非緊急諮詢的預約，從而影響了兒童神經系統疾病的診斷和治療。新設備和技術的引進也受到醫療保健系統的財務負擔和病患就診次數減少的影響。

預計神經外科設備產業在預測期內將是最大的。

由於專門用於治療兒童神經系統問題的手術器械和設備，神經外科設備部分預計將佔據最大佔有率。其中包括各種儀器，包括兒童用大小的神經科學用內視鏡、顱骨固定裝置、微創神經外科器械以及針對水腦症和先天性異常等疾病的患者專用植入。此外，它們的設計考慮了兒童患者的特殊解剖和發育需求，使神經外科醫生能夠提供精確可靠的治療，並推動該領域的發展。

預計癲癇領域在預測期內複合年成長率最高

由於兒童癲癇盛行率不斷上升以及創新設備的開發，預計癲癇領域在預測期內將出現最高的複合年成長率。其中包括監測大腦活動的腦電圖、抗癲癇藥物、迷走神經刺激設備神經刺激設備和癲癇警報。此外，對用於診斷、監測和治療兒童患者癲癇發作的設備的重視對於兒童癲癇的治療至關重要，從而推動了這一領域的擴展。

佔有率最大的地區

在估計期間，北美佔據最大的市場佔有率。隨著遠端醫療的普及，兒童神經病學服務變得更加廣泛。神經影像學和腦電圖領域的新發展包括較小的、適合兒童的設備，使兒童測試更加準確和舒適。美國、加拿大和墨西哥等國家正在透過神經刺激技術和資料分析的進步來改善癲癇等疾病的治療選擇，從而改善資料解釋，從而推動該地區的成長。

複合年成長率最高的地區：

由於歐洲藥品管理局 (EMA) 和國家衛生當局等監管機構對這些設備實施嚴格的安全性和有效性標準，預計歐洲在預測期內將呈現最高的複合年成長率。美敦力 (Medtronic)、雅培 (Abbott) 實驗室、西門子醫療 (Siemens Healthineers) 和波士頓科學公司 (Boston Scientific Corporation) 等主要公司正在為先進兒童用專用診斷工具、治療設備和監測解決方案的開發和採用做出貢獻。此外，在許多歐洲國家，這些設備的成本通常由健康保險或公共醫療保健系統承擔，支持在該地區的擴張。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球兒童神經設備市場：依產品類型

  • 神經外科設備
  • 腦脊髓液管理裝置
  • 神經刺激裝置
  • 神經介入裝置
  • 其他產品類型

第6章全球兒童神經設備市場：依病理狀況

  • 發作
  • 中風
  • 水腦症
  • 腫瘤學
  • 其他條件

第7章全球兒童神經設備市場：依年齡層

  • 0-5歲
  • 5-10年
  • 10-15歲

第8章全球兒童神經設備市場：按服務和治療分類

  • 巴氯芬鞘內注射治療
  • 迷走神經刺激
  • 腦電圖測試
  • 神經學評估
  • 其他服務和治療

第9章全球兒童神經科設備市場：依神經科專業分類

  • 神經肌肉的
  • 神經免疫學
  • 神經腫瘤學
  • 新生兒神經病學

第10章全球兒童神經設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 其他最終用戶

第11章全球兒童神經設備市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第12章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司簡介

  • Medtronic
  • Elana, Inc.
  • Stryker Corporation
  • Inova Healthcare System
  • Boston Scientific Corporation
  • The Nemours Foundation
  • Integra LifeSciences Corporation
  • B.Braun Melsungen AG
  • Abbott Laboratories
  • St. Jude Medical, LLC
  • Zimmer Biomet Holding Inc.
  • LivaNova PLC
  • Natus Medical Incorporated
  • Karl Storz SE & Co. KG
Product Code: SMRC24606

According to Stratistics MRC, the Global Pediatric Neurology Devices Market is accounted for $3.3 billion in 2023 and is expected to reach $6.4 billion by 2030 growing at a CAGR of 9.8% during the forecast period. Medical equipment made especially for the diagnosis, observation, and treatment of neurological diseases in children is known as pediatric neurology equipment. These devices treat disorders including epilepsy, cerebral palsy, and developmental delays, which include a variety of instruments such as electroencephalography (EEG) machines, pediatric MRIs, and CT scanners for rehabilitation.

According to the Migraine Research Foundation report, it has been observed that half of all migraine sufferers have their first attack before the age of 12 and migraine has even been reported to in 18 months old children.

Market Dynamics:

Driver:

Rising demand in government programs and projects

The government initiatives provide funds, encourage teamwork, and foster creativity in the field of pediatric neurology by supporting the development of advanced diagnostic and treatment devices, ultimately improving patient outcomes. Additionally, such initiatives raise awareness about pediatric neurological disorders and the importance of specialized care. Therefore, pediatric neurology devices will continue to develop and innovate as long as governments continue to place a high priority on pediatric healthcare and research, which are driving this market's growth.

Restraint:

High cost

The development and production of specialized pediatric neurology devices often involve extensive research, leading to substantial costs. These high costs can result in inflated prices for devices, making them unaffordable for many patients and healthcare providers. The financial strain on healthcare systems can limit their ability to invest in the latest technologies and advancements in pediatric neurology treatment. Additionally, the possible financial strain on patients, healthcare providers, and healthcare systems is one major drawback of the high pricing in the pediatric neurology device industry.

Opportunity:

Technological advancements

The ongoing innovation in medical technology leads to the development of more effective and minimally invasive devices for diagnosing, monitoring, and treating pediatric neurological disorders. This progress includes advanced neuroimaging techniques, neurostimulation devices, and surgical tools that enhance the precision and safety procedures. Furthermore, these innovations improve patient outcomes, reduce treatment-related discomfort, and contribute to a better quality of life for pediatric patients by providing healthcare professionals with increasingly sophisticated tools, which is boosting this market expansion.

Threat:

Lack of awareness

The restricted adoption and utilization of pediatric neurology equipment is a significant drawback resulting from a lack of understanding. Patients, caregivers, and healthcare professionals may not be aware of all the technologies that are available or all of their potential advantages. In addition, this may result in pediatric neurology equipment being neglected or adopted more slowly, which would ultimately affect patient treatment. The lack of awareness may contribute to a slower pace of innovation and research in the field, thereby impeding this market size.

COVID-19 Impact

The COVID-19 pandemic has had negative impacts on the pediatric neurology device market, primarily due to disruptions in healthcare systems and economic uncertainties. Lockdowns and restrictions led to a reduction in elective procedures and non-urgent medical appointments, affecting the diagnosis and treatment of pediatric neurological conditions. The adoption of new gadgets and technology was also impacted by the financial strains placed on healthcare systems and the decline in patient visits.

The neurosurgery devices segment is expected to be the largest during the forecast period

The neurosurgery devices segment is estimated to hold the largest share due to surgical instruments and equipment specifically made for treating neurological problems in children. This covers a broad spectrum of devices, including pediatric-sized neuroendoscopes, cranial fixation devices, minimally invasive neurosurgical instruments, and patient-specific implants for ailments such as hydrocephalus and congenital abnormalities. Additionally, these enable neurosurgeons to carry out accurate and secure treatments as they are designed with the special anatomical and developmental needs of pediatric patients, which are driving this segment's growth.

The seizures segment is expected to have the highest CAGR during the forecast period

The seizures segment is anticipated to have highest CAGR during the forecast period due to the increasing prevalence of pediatric epilepsy and the ongoing development of innovative devices. This includes electroencephalography (EEG) machines for monitoring brain activity, anti-seizure medications, neurostimulation devices like vagus nerve stimulators, and seizure alarms. Furthermore, it focuses on devices designed to diagnose, monitor, and treat seizures in pediatric patients and are crucial in the management of pediatric epilepsy which are thereby boosting this segment's expansion.

Region with largest share:

North America commanded the largest market share during the extrapolated period. Pediatric neurology services are now more widely accessible due to the rise in popularity of telemedicine alternatives. New developments in the field of neuroimaging and EEG include smaller, more kid-friendly equipment that makes examinations of children more accurate and comfortable. Countries such as the United States, Canada, and Mexico have improved therapy options for diseases like epilepsy due to developments in neurostimulation techniques and data analytics to improve data interpretation, which are propelling this region's growth.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to the regulatory organizations like the European Medicines Agency (EMA) and national health agencies which impose strict safety and efficacy standards for these devices. Major Key players such as Medtronic plc, Abbott Laboratories, Siemens Healthineers and Boston Scientific Corporation contribute to development and adoption of sophisticated diagnostic tools, therapeutic devices, and monitoring solutions tailored specifically for children. Furthermore, the cost of these devices is frequently covered by health insurance and public healthcare systems in many European nations which are driving this region's expansion.

Key players in the market:

Some of the key players in the Pediatric Neurology Devices Market include Medtronic, Elana, Inc., Stryker Corporation, Inova Healthcare System, Boston Scientific Corporation, The Nemours Foundation, Integra LifeSciences Corporation, B.Braun Melsungen AG, Abbott Laboratories, St. Jude Medical, LLC, Zimmer Biomet Holding Inc., LivaNova PLC, Natus Medical Incorporated and Karl Storz SE & Co. KG.

Key Developments:

In October 2023, Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter Alpha™ Spinal Cord Stimulator (SCS) Systems for the treatment of painful diabetic peripheral neuropathy (DPN), a complication of diabetes that can affect the lower extremities of the body.

In September 2023, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept® Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain.

In June 2023, Amcor the American Diabetes Association® and Abbott announced collaboration aimed at better understanding how diabetes technology like continuous glucose monitoring (CGM) systems can help people living with diabetes make informed decisions about their food and activity.

In March 2023, Somatus, the nation's leading and largest value-based kidney Care Company, and Inova Health System announce the new Nurse Navigator Program launch, an innovative addition to the already successful partnership.

Product Types Covered:

  • Neurosurgery Devices
  • Cerebrospinal Fluid Management Devices
  • Neurostimulation Devices
  • Interventional Neurology Devices
  • Other Product Types

Conditions Covered:

  • Seizures
  • Stroke
  • Hydrocephalus
  • Oncology
  • Other Conditions

Age Group Covered:

  • 0-5 Years
  • 5-10 Years
  • 10-15 Years

Service and Treatments Covered:

  • Intrathecal baclofen therapy
  • Vagal nerve stimulation
  • Electroencephalogram
  • Neurological Evaluations
  • Other Service and Treatments

Neurological Subspecialties Covered:

  • Neuromuscular
  • Neuroimmunology
  • Neuro-oncology
  • Neonatal Neurology

End Users Covered:

  • Ambulatory surgery centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pediatric Neurology Devices Market, By Product Type

  • 5.1 Introduction
  • 5.2 Neurosurgery Devices
  • 5.3 Cerebrospinal Fluid Management Devices
  • 5.4 Neurostimulation Devices
  • 5.5 Interventional Neurology Devices
  • 5.6 Other Product Types

6 Global Pediatric Neurology Devices Market, By Condition

  • 6.1 Introduction
  • 6.2 Seizures
  • 6.3 Stroke
  • 6.4 Hydrocephalus
  • 6.5 Oncology
  • 6.6 Other Conditions

7 Global Pediatric Neurology Devices Market, By Age Group

  • 7.1 Introduction
  • 7.2 0-5 Years
  • 7.3 5-10 Years
  • 7.4 10-15 Years

8 Global Pediatric Neurology Devices Market, By Service and Treatment

  • 8.1 Introduction
  • 8.2 Intrathecal baclofen therapy
  • 8.3 Vagal nerve stimulation
  • 8.4 Electroencephalogram
  • 8.5 Neurological Evaluations
  • 8.6 Other Service and Treatments

9 Global Pediatric Neurology Devices Market, By Neurological Subspecialties

  • 9.1 Introduction
  • 9.2 Neuromuscular
  • 9.3 Neuroimmunology
  • 9.4 Neuro-oncology
  • 9.5 Neonatal Neurology

10 Global Pediatric Neurology Devices Market, By End User

  • 10.1 Introduction
  • 10.2 Ambulatory surgery centers
  • 10.3 Hospitals
  • 10.4 Other End Users

11 Global Pediatric Neurology Devices Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Medtronic
  • 13.2 Elana, Inc.
  • 13.3 Stryker Corporation
  • 13.4 Inova Healthcare System
  • 13.5 Boston Scientific Corporation
  • 13.6 The Nemours Foundation
  • 13.7 Integra LifeSciences Corporation
  • 13.8 B.Braun Melsungen AG
  • 13.9 Abbott Laboratories
  • 13.10 St. Jude Medical, LLC
  • 13.11 Zimmer Biomet Holding Inc.
  • 13.12 LivaNova PLC
  • 13.13 Natus Medical Incorporated
  • 13.14 Karl Storz SE & Co. KG

List of Tables

  • Table 1 Global Pediatric Neurology Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Pediatric Neurology Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Pediatric Neurology Devices Market Outlook, By Neurosurgery Devices (2021-2030) ($MN)
  • Table 4 Global Pediatric Neurology Devices Market Outlook, By Cerebrospinal Fluid Management Devices (2021-2030) ($MN)
  • Table 5 Global Pediatric Neurology Devices Market Outlook, By Neurostimulation Devices (2021-2030) ($MN)
  • Table 6 Global Pediatric Neurology Devices Market Outlook, By Interventional Neurology Devices (2021-2030) ($MN)
  • Table 7 Global Pediatric Neurology Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 8 Global Pediatric Neurology Devices Market Outlook, By Condition (2021-2030) ($MN)
  • Table 9 Global Pediatric Neurology Devices Market Outlook, By Seizures (2021-2030) ($MN)
  • Table 10 Global Pediatric Neurology Devices Market Outlook, By Stroke (2021-2030) ($MN)
  • Table 11 Global Pediatric Neurology Devices Market Outlook, By Hydrocephalus (2021-2030) ($MN)
  • Table 12 Global Pediatric Neurology Devices Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 13 Global Pediatric Neurology Devices Market Outlook, By Other Conditions (2021-2030) ($MN)
  • Table 14 Global Pediatric Neurology Devices Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 15 Global Pediatric Neurology Devices Market Outlook, By 0-5 Years (2021-2030) ($MN)
  • Table 16 Global Pediatric Neurology Devices Market Outlook, By 5-10 Years (2021-2030) ($MN)
  • Table 17 Global Pediatric Neurology Devices Market Outlook, By 10-15 Years (2021-2030) ($MN)
  • Table 18 Global Pediatric Neurology Devices Market Outlook, By Service and Treatment (2021-2030) ($MN)
  • Table 19 Global Pediatric Neurology Devices Market Outlook, By Intrathecal baclofen therapy (2021-2030) ($MN)
  • Table 20 Global Pediatric Neurology Devices Market Outlook, By Vagal nerve stimulation (2021-2030) ($MN)
  • Table 21 Global Pediatric Neurology Devices Market Outlook, By Electroencephalogram (2021-2030) ($MN)
  • Table 22 Global Pediatric Neurology Devices Market Outlook, By Neurological Evaluations (2021-2030) ($MN)
  • Table 23 Global Pediatric Neurology Devices Market Outlook, By Other Service and Treatments (2021-2030) ($MN)
  • Table 24 Global Pediatric Neurology Devices Market Outlook, By Neurological Subspecialties (2021-2030) ($MN)
  • Table 25 Global Pediatric Neurology Devices Market Outlook, By Neuromuscular (2021-2030) ($MN)
  • Table 26 Global Pediatric Neurology Devices Market Outlook, By Neuroimmunology (2021-2030) ($MN)
  • Table 27 Global Pediatric Neurology Devices Market Outlook, By Neuro-oncology (2021-2030) ($MN)
  • Table 28 Global Pediatric Neurology Devices Market Outlook, By Neonatal Neurology (2021-2030) ($MN)
  • Table 29 Global Pediatric Neurology Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 Global Pediatric Neurology Devices Market Outlook, By Ambulatory surgery centers (2021-2030) ($MN)
  • Table 31 Global Pediatric Neurology Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 32 Global Pediatric Neurology Devices Market Outlook, By Other End Users (2021-2030) ($MN)

Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.